Status:
UNKNOWN
Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction
Lead Sponsor:
Chongqing Medical University
Conditions:
AMI
Eligibility:
All Genders
18-100 years
Brief Summary
To understand the effect of beta blockers on the prognosis of patients with acute myocardial infarction with preserved ejection fraction.
Detailed Description
The use of beta blockers is an important component of drug therapy for myocardial infarction, but in some exceptional cases, evidence-based evidence for their use is insufficient, and we seek to under...
Eligibility Criteria
Inclusion
- Patients with acute myocardial infarction
Exclusion
- Previous history of heart failure admission Killip class \> I class cancer pregnant
Key Trial Info
Start Date :
July 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04485988
Start Date
July 1 2015
End Date
July 1 2021
Last Update
June 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400016